Oragenics, Inc. (OGEN) Stock Forecast
OGEN analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.00 / 5 from 1 analysts
- Price target
- $2.00 average of analyst targets
- Upside to target
- +365.1% from the latest close
- Next earnings
- November 6, 2026
- 52-week range
- $0.43 – $1.37
OGEN analyst ratings
1 analystsNumber of analysts at each rating.
OGEN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
OGEN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$0.69 | −$0.69 | −$0.69 | −$0.76 | +9.2% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
OGEN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | 0.0% | 1 |
OGEN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
OGEN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.69 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
OGEN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; OGEN beat in 1 of 3.
What analysts expect from OGEN
1 analysts cover Oragenics; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $2.00, 365.1% above the latest close of $0.43. For 2026 the average estimate is −$0.69 per share. Oragenics beat the EPS estimate in 1 of the last 3 quarters.
Related: OGEN income statement, OGEN key metrics, OGEN chart. See the OGEN stock overview for the latest quote and news.
OGEN forecast FAQ
What is Oragenics's price target?
The average analyst price target for Oragenics is $2.00, 365.1% above the latest close of $0.43.
Is Oragenics a buy, hold or sell?
Of 1 analysts covering Oragenics, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
When does Oragenics report earnings?
Oragenics is expected to report results for the quarter ending September 30, 2026 on November 6, 2026.
Does Oragenics usually beat earnings estimates?
Oragenics reported EPS at or above the analyst estimate in 1 of the last 3 quarters.